Michael P. DiGiovanna

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

Gϋnter von Minckwitz, Chiun‐Sheng Huang, Max S. Mano et al. · New England Journal of Medicine · 2018 · 2.5K citations · Full text

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

Nancy U. Lin, Virginia F. Borges, Carey K. Anders et al. · Journal of Clinical Oncology · 2020 · 521 citations · Full text

Impact of Financial Burden of Cancer on Survivors' Quality of Life

Kathleen Fenn, Suzanne B. Evans, Ruth McCorkle et al. · Journal of Oncology Practice · 2014 · 459 citations

Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States

Sarah S. Mougalian, Pamela R. Soulos, Brigid K. Killelea et al. · Cancer · 2015 · 242 citations · Full text

Neoadjuvant Trastuzumab Induces Apoptosis in Primary Breast Cancers

Syed K. Mohsin, Heidi L. Weiss, Maya Gutierrez et al. · Journal of Clinical Oncology · 2005 · 241 citations · Full text